Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

144
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
144
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

403
Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
403
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

201
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
201
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

29
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
29
Dialysis01:15

Dialysis

901
Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
901
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

411
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
411

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systemic glucocorticoids use in post-COVID-syndrome patients does not affect retinal microcirculation.

Angiogenesis·2024
Same author

[Interdisciplinary ultrasound-guided, minimally invasive autopsy in COVID-19-deceased patients in the intensive care unit of a university hospital : A proof-of-concept study].

Pathologie (Heidelberg, Germany)·2023
Same author

[Prospective monitoring of a university rheumatology outpatient clinic throughout the first wave of the COVID-19 pandemic : What lessons can be learned?]

Zeitschrift fur Rheumatologie·2020
Same author

Adult macrophage activation syndrome-haemophagocytic lymphohistiocytosis: 'of plasma exchange and immunosuppressive escalation strategies' - a single centre reflection.

Lupus·2020
Same author

Single-dose rituximab for remission induction and maintenance therapy in ANCA-associated vasculitis: a retrospective analysis of 17 patients.

Scandinavian journal of rheumatology·2014
Same author

Identification and characterization of a defective CYP3A4 genotype in a kidney transplant patient with severely diminished tacrolimus clearance.

Clinical pharmacology and therapeutics·2013
Same journal

Der nephrologe·2022
Same journal

[KDIGO guideline on the evaluation and management of candidates for kidney transplantation].

Der nephrologe·2022
Same journal

Der nephrologe·2021
Same journal

[Consensus Paper "Palliative renal care"].

Der nephrologe·2021
Same journal

[Strategies for effective treatment of ANCA-associated vasculitides with fewer side effects].

Der nephrologe·2021
Same journal

[Inhibition of the renin-angiotensin-aldosterone system].

Der nephrologe·2021
See all related articles

Related Experiment Video

Updated: Oct 13, 2025

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

2.8K

[Innovations in peritoneal dialysis].

R Hausinger1, C Schmaderer1, U Heemann1

  • 1Abteilung für Nephrologie, Klinikum rechts der Isar, Technische Universität München, Ismaningerstr. 22, 81675 München, Deutschland.

Der Nephrologe
|November 17, 2021
PubMed
Summary
This summary is machine-generated.

Peritoneal dialysis is resurging for acute kidney failure due to its simplicity and low resource needs, especially after the COVID-19 pandemic. Future innovations like wearable artificial kidneys and dialysate regeneration promise further advancements.

Keywords:
Acute kidney injury requiring dialysisAlanyl-glutamine supplementationImmunomodulatory adjuvantsPercutaneous catheterizationWearable cyclers

More Related Videos

Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion
06:23

Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion

Published on: May 23, 2025

789
Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

15.5K

Related Experiment Videos

Last Updated: Oct 13, 2025

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

2.8K
Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion
06:23

Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion

Published on: May 23, 2025

789
Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

15.5K

Area of Science:

  • Nephrology
  • Biomedical Engineering

Context:

  • Peritoneal dialysis (PD) was historically common for acute kidney failure but declined in Western countries.
  • It remains vital in resource-limited regions due to simplicity and low cost.
  • The COVID-19 pandemic revived global interest in PD as a safe acute dialysis option.

Purpose:

  • To review the current status and future prospects of peritoneal dialysis.
  • To highlight recent advancements and potential innovations in PD therapy.

Summary:

  • Biocompatible solutions introduced 20 years ago aimed to reduce PD complications, though evidence remains limited.
  • Immunomodulatory adjuvants offer potential for improved local immunity and prevention of peritoneal function loss.
  • Wearable artificial kidney technology and intensified dialysis with minimal dialysate volumes are emerging possibilities.

Impact:

  • PD offers a sustainable dialysis option, with dialysate regeneration potentially conserving water and reducing CO2 emissions.
  • Innovations may enhance PD efficacy and patient outcomes, making it a more viable treatment globally.
  • The resurgence of PD reflects its adaptability and potential to address healthcare challenges, including resource limitations and pandemics.